home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410o.zip
/
M94A2989.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
3KB
|
52 lines
Document 2989
DOCN M94A2989
TI Testicular germ-cell tumors (GCT) in 23 patients (PTS) with HIV
infection. GICAT (Italian Cooperative Group on AIDS and Tumors).
DT 9412
AU Bernardi D; Errante D; Vaccher E; Tumolo S; Spina M; Nasti G; Marini B;
Repetto L; Pizzoccaro G; Monfardini S; et al; Centro di Riferimento
Oncologico, Aviano, Italy.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):179 (abstract no. PB0143). Unique
Identifier : AIDSLINE ICA10/94369586
AB Between November 1986 and January 1994, 23 cases of GCT were observed
within the GICAT. Thirteen pts had seminoma (SGCT) and 10 non seminoma
(NSGCT). Sixteen were IVDUs, 3 homosexuals, 2 IVDU+homosexual, 1
hemophiliac and 1 with unknown risk factor. At diagnosis 1 (4.3%)
patient had AIDS, 5 (21.7%) pts ARC, 4 (17.4%) PGL and the other cases
(56.5%) were asymptomatic. The median number of CD4+ cells was 200/mmc
for SGCT and 332/mmc for NSGCT. Ten of 13 pts with stage I and II SGCT
received infradiaphragmatic irradiation as primary treatment after
surgery, and 2 pts refused therapy. One patient with advanced disease
treated with cisplatin, VP-16 and bleomycin (PEB) achieved CR and died
of AIDS after 12 months. Out of 12 evaluable pts, 5 pts are alive (4 in
CR and 1 in PD) with a median survival of 24 months, 4 died of AIDS (all
of them had no evidence of disease), 1 patient died of accidental reason
(after 24 months from diagnosis), 1 patient died of progression of
disease after 38 months from diagnosis, 1 was lost to follow up. Out of
10 pts with NSGCT, 2 cases with stage I refused therapy and were lost to
follow up. Of the 2 other pts with stage II, 1 underwent retroperitoneal
lymphnode dissection, was treated with chemotherapy (PEB x 3 cycles) and
died of AIDS after 47 months from diagnosis, while the other one after
diagnosis was lost to follow up. Five pts with advanced disease treated
with PEB for 3-4 cycles achieved a CR (median duration 39 months); three
of these patients died of AIDS with no evidence of disease, 1 patient is
alive after 35 months and 1 patient relapsed after 5 months and died of
progressive disease. A PR was obtained in a patient with PVB. PEB was
overall well tolerated with no further development of opportunistic
infections. All pts refusing therapy and lost to follow up were IVDUs.
In conclusion, pts with GCT can be offered standard oncological therapy
with similar results to those of the general population, but
antiretroviral therapy should also be applied in a combined approach to
better control the underlying HIV infection.
DE Antineoplastic Agents, Combined/THERAPEUTIC USE Cause of Death
Combined Modality Therapy Follow-Up Studies Human HIV
Infections/MORTALITY/PATHOLOGY/*THERAPY Male Neoplasm Staging
Neoplasms, Germ Cell and Embryonal/MORTALITY/PATHOLOGY/*THERAPY
Seminoma/MORTALITY/PATHOLOGY/*THERAPY Support, Non-U.S. Gov't Survival
Rate Testicular Neoplasms/MORTALITY/PATHOLOGY/*THERAPY MEETING
ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).